Kelley v. Secretary of Health and Human Services ( 2022 )


Menu:
  • In the Anited States Court of Federal Claims
    OFFICE OF SPECIAL MASTERS
    No. 19-1111V
    (not to be published)
    ok ok ok ok ok ok ok ok ok ok ok ok ok Ok ok ok ok ok ok ok ok ok ok ok ok
    *
    DEBORAH KELLEY, :
    * Filed: March 8, 2022
    Petitioner, *
    *
    *
    Vv. * Decision by Stipulation; Damages;
    * Influenza (“Flu”) Vaccine; Guillain-Barré
    SECRETARY OF HEALTH AND : syndrome.
    HUMAN SERVICES, Ce
    *
    Respondent. *
    *
    *
    2h 2K Ok Ok ok ok ok ok OK OK ok ok ok Ok Ok OK OK OK OK OK Ok OK OK OK OK
    Jessica Powell, Burg Simpson Eldredge Hersh & Jardine, Cincinnati, OH, for Petitioner
    Felicia Langel, U.S. Department of Justice, Washington, DC, for Respondent
    DECISION ON JOINT STIPULATION!
    On July 31, 2019, Deborah Kelley (“Petitioner”) filed a petition, seeking compensation
    under the National Vaccine Injury Compensation Program (“the Vaccine Program’”).” Pet., ECF
    No. 1. Petitioner alleges she suffered from a Table injury of Guillain-Barré syndrome as a result
    of the influenza (“flu”) vaccination she received on October 23, 2018. See Stipulation { 2, 4, dated
    March 8, 2022 (ECF No. 54); see also Petition.
    Respondent denies “that petitioner suffered a Table injury of GBS after a flu vaccine,
    ' Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
    on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 
    44 U.S.C. § 3501
     (2012). This means the Decision will be available to anyone with access to the internet. As
    provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of
    certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen
    days within which to request redaction “of any information furnished by that party: (1) that is a trade secret
    or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
    or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.”
    Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Jd.
    * The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
    No. 99-660, 
    100 Stat. 3755
     (codified as amended at 42 U.S.C. §§ 300aa-10-34 (2012)) (hereinafter
    “Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
    pertinent subparagraph of 42 U.S.C. § 300aa.
    denies that the flu vaccine caused petitioner’s alleged GBS or any other injury or condition, and
    denies that petitioner’s alleged injury or condition is a sequela of a vaccine-related injury.” See
    Stipulation {[ 6. Nonetheless, both parties, while maintaining their above-stated positions, agreed
    in a stipulation filed March 8, 2022 that the issues before them can be settled and that a decision
    should be entered awarding Petitioner compensation.
    I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
    is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
    therein.
    The stipulation awards:
    a lump sum of $80,000.00 in the form of a check payable to petitioner.
    Stipulation J 8. This award represents compensation for all damages that would be available under
    42 U.S.C. § 300aa-15(a).
    I approve a Vaccine Program award in the requested amount set forth above to be made to
    Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
    the Court is directed to enter judgment herewith.
    IT IS SO ORDERED.
    s/ Katherine E. Oler
    Katherine E. Oler
    Special Master
    > Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
    renouncing their right to seek review.
    THE UNITED STATES COURT OF FEDERAL CLAIMS
    OFFICE OF SPECIAL MASTERS
    DEBORAH KELLEY,
    Petitioner,
    v. No. 19-1111V
    Special Master Katherine E. Oler
    SECRETARY OF HEALTH AND ECF
    HUMAN SERVICES,
    Respondent.
    STIPULATION
    The parties hereby stipulate to the following matters:
    1. Petitioner, Deborah Kelley, filed a petition for vaccine compensation under the
    National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to -34 (“Vaccine
    Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt
    of the influenza (“flu”) vaccine, which is contained in the Vaccine Injury Table (“Table”), 
    42 C.F.R. § 100.3
    (a).
    2. Petitioner received the flu vaccine on or about October 23, 2018.
    3. The vaccine was administered within the United States.
    4. Petitioner alleges that the flu vaccine caused her to develop Guillain-Barré Syndrome
    (“GBS”), and that she experienced the residual effects of this condition for more than six
    months.
    5. Petitioner represents that there has been no prior award or settlement of a civil action
    for damages as a result of her condition.
    6. Respondent denies that petitioner suffered a Table injury of GBS after a flu vaccine,
    denies that the flu vaccine caused petitioner’s alleged GBS or any other injury or condition, and
    denies that petitioner’s alleged injury or condition is a sequela of a vaccine-related injury.
    7. Maintaining their above-stated positions, the parties nevertheless now agree that the
    issues between them shall be settled, and that a decision should be entered awarding the
    compensation described in paragraph 8 of this Stipulation.
    8. As soon as practicable after entry of judgment reflecting a decision consistent with the
    terms of this Stipulation, and after petitioner has filed an election to receive compensation
    pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue
    the following vaccine compensation payment:
    A lump sum of $80,000,000 in the form of a check payable to petitioner. This
    amount represents compensation for all damages that would be available under
    42 U.S.C. § 300aa-15(a).
    9. As soon as practicable after the entry of judgment on entitlement in this case, and after
    petitioner has filed both a proper and timely election to receive compensation pursuant to
    42 U.S.C. § 300aa-21(a)(1) and an application, the parties will submit to further proceedings
    before the special master to award reasonable attorneys’ fees and costs incurred in proceeding
    upon this petition.
    10. Petitioner and her attorney represent that they have identified to respondent all
    known sources of payment for items or services for which the Vaccine Program is not primarily
    liable under 42 U.S.C. § 300aa-15(g), including State compensation programs, insurance
    policies, Federal or State health benefits programs (other than Title XIX of the Social Security
    Act), or entities that provide health services on a pre-paid basis.
    11. Payment made pursuant to paragraph 8 of this Stipulation, and any amount awarded
    pursuant to paragraph 9, will be made in accordance with 42 U.S.C. § 300aa-15(i) and subject to
    the availability of sufficient statutory funds.
    12. The parties and their attorneys further agree and stipulate that, except for any award
    for attorneys’ fees and litigation costs and past unreimbursable expenses, the money provided
    pursuant to this Stipulation will be used solely for the benefit of petitioner as contemplated by a
    strict construction of 42 U.S.C. § 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C.
    § 300aa-15(g) and (h).
    13. In return for the payment described in paragraph 8, and any amount awarded
    pursuant to paragraph 9, petitioner, in her individual capacity and on behalf of her heirs,
    executors, administrators, successors, and/or assigns, does forever irrevocably and
    unconditionally release, acquit, and discharge the United States and the Secretary of Health and
    Human Services from any and all actions or causes of action (including agreements, judgments,
    claims, damages, loss of services, expenses, and all demands of whatever kind or nature) that
    have been brought, could have been brought, or could be timely brought in the Court of Federal
    Claims under the Vaccine Program on account of, or in any way growing out of, any and all
    known or unknown, suspected or unsuspected personal injuries to, or death of, petitioner
    resulting from, or alleged to have resulted from, the flu vaccine administered on or about
    October 23, 2018, as alleged by petitioner in a petition for vaccine compensation filed on or
    about July 31, 2019, in the United States Court of Federal Claims as petition No. 19-1111V.
    14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
    upon proper notice to the Court of Federal Claims on behalf of either or both of the parties.
    15. Ifthe special master fails to issue a decision in complete conformity with the terms
    of this Stipulation, or if the Court of Federal Claims fails to enter judgment in conformity with a
    decision that is in complete conformity with the terms of this Stipulation, then the parties’
    settlement and this Stipulation shall be voidable at the sole discretion of either party.
    16. This Stipulation expresses a full and complete negotiated settlement of liability and
    damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
    as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
    parties hereto to make any payment, or do any act or thing, other than is herein expressly stated
    and clearly agreed to. The parties further agree and understand that the award described in this
    Stipulation may reflect a compromise of the parties’ respective positions as to liability and/or
    amount of damages, and, further, that a change in the nature of the injury or condition, or in the
    items of compensation sought, is not grounds to modify or revise this agreement.
    17. This Stipulation shall not be construed as an admission by the United States or the
    Secretary of Health and Human Services that the flu vaccine caused petitioner’s alleged GBS or
    any other injury or condition.
    18. All rights and obligations of petitioner hereunder shall apply equally to petitioner’s
    heirs, executors, administrators, successors, and/or assigns.
    END OF STIPULATION
    Respectfully submitted,
    PETITIONER:
    C Jetan cf Hein
    DEBORAH KELLEY’
    ATTORNEY OF RECORD FOR
    PETITIONER:
    SSICA L. POWELL
    URG SIMPSON
    ELDREDGE HERSH & JARDINE, P.C.
    312 Walnut Street, Suite 2090
    Cincinnati, OH 45202
    jpowell@burgsimpson.com
    AUTHORIZED REPRESENTATIVE
    OF THE SECRETARY OF HEALTH
    AND HUMAN SERVICES:
    Digitally signed by George R.
    George R. Grimes -S14 Grimes -si4
    Date: 2022.03.01 15:41:30 -05'00"
    CDR GEORGE REED GRIMES, MD, MPH
    Director, Division of Injury
    Compensation Programs
    Health Systems Bureau
    Health Resources and Services
    Administration
    U.S. Department of Health
    and Human Services
    5600 Fishers Lane, 08N146B
    Rockville, MD 20857
    DATE: 02/0@)2622_
    AUTHORIZED REPRESENTATIVE
    OF THE ATTORNEY GENERAL:
    da ctrrkg Pe
    HEATHER L. PEARLMAN
    Deputy Director
    Torts Branch
    Civil Division
    U.S. Department of Justice
    P.O. Box 146
    Benjamin Franklin Station
    Washington, D.C. 20044-0146
    ATTORNEY OF RECORD FOR
    RESPONDENT:
    AgheaD Lan
    by CHorttin L
    CRP =...
    FELICIA D. LANGEL
    Trial Attorney
    Torts Branch
    Civil Division
    U.S. Department of Justice
    P.O. Box 146
    Benjamin Franklin Station
    Washington, D.C. 20044-0146
    felicia.d.langel@usdoj.gov
    

Document Info

Docket Number: 19-1111

Judges: Katherine E. Oler

Filed Date: 4/11/2022

Precedential Status: Non-Precedential

Modified Date: 4/14/2022